Which of the following is an NSAID for Alzheimer’s disease, that lead to Phase III clinical trials?
(a) Bapineuzumab
(b) Alzhemed
(c) Flurizan
(d) Doxil
I had been asked this question in an interview.
I would like to ask this question from Chemical Basis of Life topic in portion Chemical Basis of Life of Cell Biology